Abstract: An implantable medical device contains a hermetic battery. The hermetic battery contains a hermetically sealed battery housing defining an internal chamber, an electrochemical cell disposed within the internal chamber, and an electronic module disposed within the internal chamber. The electronic module is electrically conductively connected to the electrochemical cell, and the electronic module is arranged in the electrochemical cell.

Abstract: An implantable medical device (1) includes a resonant circuit, a switch (Si), and a control circuit (CC). The resonant circuit includes an inductive charging coil (L1), a first capacitor and (C1?), and a second capacitor (C2?). The inductive charging coil (L1) is electrically connected to the first capacitor (C1?). The inductive charging coil (L1) is electrically connected to the second capacitor (C2?) when the switch (S1) is closed and electrically disconnected from the second capacitor (C2?) when the switch (Si) is open such that the resonant circuit comprises a first resonance frequency when the switch (S1) is open and a second resonance frequency when the switch (S1) is closed. The second resonance frequency is different from the first resonance frequency. The control circuit (CC) is configured to apply a frequency modulated control signal or a pulse width modulated control signal to the switch (S1) for controlling the switch (S1).

Abstract: An implantable medical device contains a hermetic battery. The hermetic battery contains a hermetically sealed battery housing defining an internal chamber, an electrochemical cell disposed within the internal chamber, and an electronic module disposed within the internal chamber. The electronic module is electrically conductively connected to the electrochemical cell, and the electronic module is arranged in the electrochemical cell.

Abstract: The present invention is directed to a multi-mode crystal oscillator system selectively configurable to minimize power consumption or noise generation. Such a system is particularly applicable to the communication system of an implantable device, e.g., the microstimulator/sensor device described in U.S. Pat. Nos. 6,164,284 and 6,185,452. In such devices, their small size limits the size of the battery contained within and thus makes it essential to minimize power consumption. Additionally, the small size and battery capacity result in a limited transmission power. Furthermore, the small size limits the antenna efficiency which makes it desirable to limit any noise generation to maximize the signal-to-noise level of the resulting receive signal. Accordingly, embodiments of the present invention alternatively supply power to the oscillator in either a first mode that minimizes power consumption or a second mode that minimizes noise generation.

Abstract: A system for improving the biocompatibility of medical devices present within a patient's body. In one embodiment, the present subject matter reduces the thrombogenicity of polyurethane materials in contact with the blood of a patient. In one embodiment, the medical device has a polymeric wall and a coating of polyurethane, said coating of polyurethane having the same chemical composition throughout the thickness and displaying an antithrombogenic effect when inserted into a patient's body in contact with blood for a period of at least twenty-four hours. The present subject matter relates to the manufacture and treatment of polymeric materials that may be inserted as medical devices, accessories, implants or replacements into animal bodies, such as the human body.

Abstract: The present invention is directed to a multi-mode crystal oscillator system selectively configurable to minimize power consumption or noise generation. Such a system is particularly applicable to the communication system of an implantable device, e.g., the microstimulator/sensor device described in U.S. Pat. Nos. 6,164,284 and 6,185,452. In such devices, their small size limits the size of the battery contained within and thus makes it essential to minimize power consumption. Additionally, the small size and battery capacity result in a limited transmission power. Furthermore, the small size limits the antenna efficiency which makes it desirable to limit any noise generation to maximize the signal-to-noise level of the resulting receive signal. Accordingly, embodiments of the present invention alternatively supply power to the oscillator in either a first mode that minimizes power consumption or a second mode that minimizes noise generation.

Abstract: An apparatus and method for forming a RAM data memory that generates predictable noise/interference components that are coherent with each write cycle and essentially independent of the data content of the RAM data memory. The RAM data memory is comprised of a plurality of cells, each representing a data bit, which are selectively addressable as memory bytes formed of multiple bits. Each cell is formed of two sets of cross-coupled transistors. By causing each set of cross-coupled transistors to be set to a common voltage level at the beginning of a write cycle before setting one set of transistors to a low level and the one set of transistors to be set to a high level (thus representing a desired data bit value), the associated noise/interference components of the power drain are data independent. Furthermore, the data-independent noise occurs at frequencies at or above the write cycle rate.

Abstract: The present invention provides a method for improving the bio-compatibility of devices, especially medical devices which are invasively present within a patient's body and the improved medical device. The present invention particularly reduces the thrombogenicity of polyurethane materials in contact with the blood of a living patient. The method comprises providing a bio-compatible medical device having polymeric polyurethane components thereon, exposing the polyurethane components of the medical device to polar solvents for said polymeric components while the polar solvents are in the vapor phase, and allowing said vapor phase exposure to continue for a sufficient amount of time as to reduce at least some irregular or sharp features on the surface of the polymeric component.

Abstract: The present invention provides a method for improving the biocompatibility of devices, especially medical devices which are invasively present within a patient's body and the improved medical device. The present invention particularly reduces the thrombogenicity of polyurethane materials in contact with the blood of a living patient. The method comprises providing a biocompatible medical device having polymeric polyurethane components thereon, exposing the polyurethane components of the medical device to polar solvents for said polymeric components while the polar solvents are in the vapor phase, and allowing said vapor phase exposure to continue for a sufficient amount of time as to reduce at least some irregular or sharp features on the surface of the polymeric component.